Video consultation and treatment in the community smoking cessation therapy success rates in patients with mental illness: a randomized controlled trial

References

• Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry. 1997;171(6):502–508. doi: 10.1192/bjp.171.6.502.
   PubMedGoogle Scholar
• Leucht S, Burkard T, Henderson J, et al. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand. 2007;116(5):317–333. doi: 10.1111/j.1600-0447.2007.01095.x.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Musliner KL, Benros ME, et al. Mortality and life expectancy in persons with severe unipolar depression. J Affect Disord. 2016;193:203–207. doi: 10.1016/j.jad.2015.12.067.
   PubMed Web of Science ®Google Scholar
• Hjorthøj C, Stürup AE, McGrath JJ, et al. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301. doi: 10.1016/S2215-0366(17)30078-0.
   PubMed Web of Science ®Google Scholar
• H MDE, Schreurs V, Vancampfort D, et al. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry. 2009;8(1):15–22. doi: 10.1002/j.2051-5545.2009.tb00199.x.
   PubMed Web of Science ®Google Scholar
• McCreadie RG, Scottish Schizophrenia Lifestyle Group. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry. 2003;183(6):534–539. doi: 10.1192/03-162.
   PubMedGoogle Scholar
• Caemmerer J, Correll CU, Maayan L. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials. Schizophr Res. 2012;140(1–3):159–168. doi: 10.1016/j.schres.2012.03.017.
   PubMed Web of Science ®Google Scholar
• Bobes J, Arango C, Garcia-Garcia M, et al. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res. 2010;119(1–3):101–109. doi: 10.1016/j.schres.2010.02.1030.
   PubMed Web of Science ®Google Scholar
• Koch MB, Diderichsen F, Grønbæk M, et al. What is the association of smoking and alcohol use with the increase in social inequality in mortality in Denmark? A nationwide register-based study. BMJ Open. 2015;5(5):e006588. doi: 10.1136/bmjopen-2014-006588.
   PubMed Web of Science ®Google Scholar
• Moltke M. Psykisk sygdom og ændringer I livsstil. 2015.
   Google Scholar
• DE Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77. doi: 10.1002/j.2051-5545.2011.tb00014.x.
   PubMed Web of Science ®Google Scholar
• Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: a population-based prevalence study. Jama. 2000;284(20):2606–2610. doi: 10.1001/jama.284.20.2606.
   PubMed Web of Science ®Google Scholar
• Flensborg-Madsen T, von Scholten MB, Flachs EM, et al. Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study. J Psychiatr Res. 2011;45(2):143–149. doi: 10.1016/j.jpsychires.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Attepe Özden S, Tekindal M, Tekindal MA. Quality of life of people with schizophrenia: a meta-analysis. Int J Soc Psychiatry. 2023;69(6):1444–1452. doi: 10.1177/00207640231164019.
   PubMed Web of Science ®Google Scholar
• Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15(6):469–494. doi: 10.2165/00023210-200115060-00005.
   PubMed Web of Science ®Google Scholar
• Schaffer SD, Yoon S, Zadezensky I. A review of smoking cessation: potentially risky effects on prescribed medications. J Clin Nurs. 2009;18(11):1533–1540. doi: 10.1111/j.1365-2702.2008.02724.x.
   PubMed Web of Science ®Google Scholar
• Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013;2013(2):Cd007253. doi: 10.1002/14651858.CD007253.pub3.
   PubMedGoogle Scholar
• Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–2520. doi: 10.1016/S0140-6736(16)30272-0.
   PubMed Web of Science ®Google Scholar
• Garcia-Portilla MP, Garcia-Alvarez L, Sarramea F, et al. It is feasible and effective to help patients with severe mental disorders to quit smoking: an ecological pragmatic clinical trial with transdermal nicotine patches and varenicline. Schizophr Res. 2016;176(2-3):272–280. doi: 10.1016/j.schres.2016.05.011.
   PubMed Web of Science ®Google Scholar
• Batra A, Petersen KU, Hoch E, et al. [Psychotherapy and pharmacotherapy for harmful tobacco use and tobacco dependency]. Nervenarzt. 2016;87(1):35–45. doi: 10.1007/s00115-015-0037-1.
   PubMed Web of Science ®Google Scholar
• Peckham E, Brabyn S, Cook L, et al. Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis. BMC Psychiatry. 2017;17(1):252. doi: 10.1186/s12888-017-1419-7.
   PubMedGoogle Scholar
• Ashton M, Rigby A, Galletly C. What do 1000 smokers with mental illness say about their tobacco use? Aust N Z J Psychiatry. 2013;47(7):631–636. doi: 10.1177/0004867413482008.
   PubMed Web of Science ®Google Scholar
• Carlson LE, Lounsberry JJ, Maciejewski O, et al. Telehealth-delivered group smoking cessation for rural and urban participants: feasi­bility and cessation rates. Addict Behav. 2012;37(1):108–114. doi: 10.1016/j.addbeh.2011.09.011.
   PubMed Web of Science ®Google Scholar
• Kim SS, Sitthisongkram S, Bernstein K, et al. A randomized controlled trial of a videoconferencing smoking cessation intervention for korean American women: preliminary findings. Int J Womens Health. 2016;8:453–462. doi: 10.2147/IJWH.S109819.
   PubMedGoogle Scholar
• De Las Cuevas C, Arredondo MT, Cabrera MF, et al. Randomized clinical trial of telepsychiatry through videoconference versus face-to-face conventional psychiatric treatment. Telemed J E Health. 2006;12(3):341–350. doi: 10.1089/tmj.2006.12.341.
   PubMed Web of Science ®Google Scholar
• Garcia-Lizana F, Munoz-Mayorga I. What about telepsychiatry? A systematic review. Prim Care Compan J Clin Psychiatry. 2010;12(2).
   PubMedGoogle Scholar
• Cahill K, Lindson-Hawley N, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;2016(5):Cd006103. doi: 10.1002/14651858.CD006103.pub7.
   PubMedGoogle Scholar
• Svicher A, Cosci F, Giannini M, et al. Item response theory analysis of fagerstrom test for cigarette dependence. Addict Behav. 2017;77:38–46. doi: 10.1016/j.addbeh.2017.09.005.
   PubMed Web of Science ®Google Scholar
• DiFranza JR, Wellman RJ, Savageau JA, et al. What aspect of dependence does the fagerstrom test for nicotine dependence measure? ISRN Addict. 2013;2013:906276–906278. doi: 10.1155/2013/906276.
   PubMedGoogle Scholar
• Gökbayrak NS, Paiva AL, Blissmer BJ, et al. Predictors of relapse among smokers: transtheoretical effort variables, demographics, and smoking severity. Addict Behav. 2015;42:176–179. doi: 10.1016/j.addbeh.2014.11.022.
   PubMed Web of Science ®Google Scholar
• Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1(1):91–111. doi: 10.1146/annurev.clinpsy.1.102803.143833.
   PubMed Web of Science ®Google Scholar
• Lindson-Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2015;(3):Cd006936. doi: 10.1002/14651858.CD006936.pub3.
   PubMed Web of Science ®Google Scholar
• Parker C, McNeill A, Ratschen E. Tailored tobacco dependence support for mental health patients: a model for inpatient and community services. Addiction. 2012;107 Suppl 2:18–25. doi: 10.1111/j.1360-0443.2012.04082.x.
   PubMed Web of Science ®Google Scholar
• Rubak S, Sandbaek A, Lauritzen T, et al. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55(513):305–312.
   PubMed Web of Science ®Google Scholar
• Forsberg L, Ernst D, Farbring CA. Learning motivational interviewing in a real-life setting: a randomised controlled trial in the Swedish prison service. Crim Behav Ment Health. 2011;21(3):177–188. doi: 10.1002/cbm.792.
   PubMed Web of Science ®Google Scholar
• Hartmann-Boyce J, Chepkin SC, Ye W, et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018;5(5):Cd000146. doi: 10.1002/14651858.CD000146.pub5.
   PubMedGoogle Scholar
• Hays JT, Ebbert JO. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. Drugs. 2010;70(18):2357–2372. doi: 10.2165/11538190-000000000-00000.
   PubMed Web of Science ®Google Scholar
• Gibbons RD, Mann JJ. Varenicline, smoking cessation, and neuropsychiatric adverse events. Am J Psychiatry. 2013;170(12):1460–1467. doi: 10.1176/appi.ajp.2013.12121599.
   PubMed Web of Science ®Google Scholar
• Jiménez-Ruiz C, Berlin I, Hering T. Varenicline: a novel pharmacotherapy for smoking cessation. Drugs. 2009;69(10):1319–1338. doi: 10.2165/00003495-200969100-00003.
   PubMed Web of Science ®Google Scholar
• Rüther T, Bobes J, De Hert M, et al. EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry. 2014;29(2):65–82. doi: 10.1016/j.eurpsy.2013.11.002.
   PubMed Web of Science ®Google Scholar
• Theng YM, Wahab S, Wahab NA, et al. Schizophrenia And nicotine dependence: what psychopharmacological treatment options are available For The duo perturbationes? Curr Drug Targets. 2019;20(2):173–181. doi: 10.2174/1389450118666171017163741.
   PubMed Web of Science ®Google Scholar
• Aubin HJ, Farley A, Lycett D, et al. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012;345:e4439. doi: 10.1136/bmj.e4439.
   PubMed Web of Science ®Google Scholar
• Wang X, Qin LQ, Arafa A, et al. Smoking cessation, weight gain, cardiovascular risk, and all-cause mortality: a meta-analysis. Nicotine Tob Res. 2021;23(12):1987–1994. doi: 10.1093/ntr/ntab076.
   PubMed Web of Science ®Google Scholar
• Cuschieri S. The CONSORT statement. Saudi J Anaesth. 2019;13(Suppl 1):S27–s30. doi: 10.4103/sja.SJA_559_18.
   PubMed Web of Science ®Google Scholar